This study reveals unique driver genes and signalling pathways in colorectal carcinoma, highlighting FAT4 and TET2's potential therapeutic roles.
Key Points
Frequent mutations in driver genes were identified in young colorectal carcinoma patients from sub-Saharan Africa, indicating distinct tumour biology characteristics.
Notably, FAT4 and TET2 emerged as crucial mutated driver genes, occurring at 26% and 15% respectively, marking them as potential therapeutic targets.
Whole exome sequencing was utilized to analyze 83 colorectal carcinoma cases, revealing unique mutation patterns in a sub-Saharan African cohort.
Findings suggest the need for targeted investigations into alternative driver genes and therapeutic strategies for early-onset colorectal carcinoma.